American Health Packaging Announces the Voluntary Nationwide Recall of Ibuprofen Tablets, USP, 600 mg, 100 Hospital Unit Dose and Oxcarbazepine Tablets, 300 mg, 100 Hospital Unit Dose FOR IMMEDIATE RELEASE - July 18, 2014 - American Health Packaging (Columbus, OH) has voluntarily recalled Lot #142588, Expiration Date, 01/2016 of Ibuprofen Tablets, USP, 600 mg, in a [...]
Pennsylvania - Protect Access to Medications Exclude Epilepsy Medications from the Prescription Drug Monitoring Program Take Action! The Pennsylvania Senate is considering a bill, SB 1180, which would expand the state's Prescription Drug Monitoring Program to include Schedule V drugs, including anti-epilepsy drugs (AEDs). The House considered a bill to expand the prescription drug monitoring [...]
FDA Warns of Serious Skin Reactions and has Approved Label Change The U.S. Food and Drug Administration (FDA) is warning the public that the anti-seizure drug Onfi (clobazam) can cause rare but serious skin reactions that can result in permanent harm and death. We have approved changes to the Onfi drug label and the patient [...]
FOR IMMEDIATE RELEASE CONTACT: Matt Flesch 847-282-1154 ONFI® (clobazam) CIV Scored Tablets and Oral Suspension Now Available in U.S. Pharmacies New Formulations Provide Dosing Flexibility for Physicians and their Patients ONFI.com Updated with New Tools and Resources for Families Deerfield, Ill. August 12, 2013 – Lundbeck announced today that ONFI (clobazam) CIV will be available [...]
